Filana Therapeutics (FLNA) Price to Earnings (2010 - 2026)
Filana Therapeutics (FLNA) posted Price to Earnings of 6.53 for Q2 2026, up 15.4% on a QoQ basis from 7.71 in Q1 2026, and down 230.85% year-over-year from 4.99 in Q2 2025.
Powered by 
Analysis
Filana Therapeutics (FLNA) Price to Earnings (2010 - 2026) Analysis & Trends
Filana Therapeutics has reported Price to Earnings for 17 years, with the latest figure at 6.53 in Q2 2026.
- On a quarterly basis, Price to Earnings fell 230.85% year-over-year to 6.53 in Q2 2026; TTM through Jun 2026 was 2.4, a 240.6% decrease from a year earlier, with the FY2025 full-year figure at 0.47, down 13.83% from the prior year.
- Price to Earnings was 6.53 for Q2 2026 at Filana Therapeutics, up from 7.71 in the prior quarter.
- The five-year high for Price to Earnings was 14.96 in Q4 2025, with the low at 82.14 in Q1 2022.
- Average Price to Earnings over 5 years is 24.79, with a median of 13.49 recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Price to Earnings jumped 466.04% in 2025, then slumped 230.85% in 2026.
- Over 5 years, Price to Earnings stood at 16.7 in 2022, then soared by 42.41% to 9.62 in 2023, then soared by 57.51% to 4.09 in 2024, then jumped by 466.04% to 14.96 in 2025, then sank by 143.62% to 6.53 in 2026.
- The last three Price to Earnings figures came in at 6.53 (Q2 2026), 7.71 (Q1 2026), and 14.96 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Filana Therapeutics | 38.14 Mn | 38.14 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.53 |
| Mar 31, 2026 | -7.71 |
| Dec 31, 2025 | 14.96 |
| Sep 30, 2025 | -12.87 |
| Jun 30, 2025 | -1.97 |
| Mar 31, 2025 | -3.08 |
| Dec 31, 2024 | -4.09 |
| Sep 30, 2024 | -50.01 |
| Jun 30, 2024 | -9.99 |
| Mar 31, 2024 | -14.11 |
| Dec 31, 2023 | -9.62 |
| Sep 30, 2023 | -26.72 |
| Jun 30, 2023 | -38.16 |
| Mar 31, 2023 | -40.56 |
| Dec 31, 2022 | -16.70 |
| Sep 30, 2022 | -80.25 |
| Jun 30, 2022 | -56.62 |
| Mar 31, 2022 | -82.14 |
| Dec 31, 2021 | -121.19 |
| Sep 30, 2021 | -255.11 |